This analysis showed that elevated expression of PKN3 significantly positively correlates with the elevated expression of p130Cas and vice versa in both patients with breast cancer and those with prostate cancer (Fig. 4A and Fig. S2A). This evidence concerns the gene PKN3 and prostate carcinoma.